The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

Peer Review reports

Original Submission
3 May 2011	Submitted	Original manuscript
7 Sep 2011	Reviewed	Reviewer Report - Gabriella Ferrandina
7 Sep 2011	Reviewed	Reviewer Report - Jack Cuzick
16 Sep 2011	Author responded	Author comments - Michael Hans Robert Eichbaum
Resubmission - Version 2
16 Sep 2011	Submitted	Manuscript version 2
Publishing
20 Oct 2011	Editorially accepted
20 Oct 2011	Article published	10.1186/1471-2407-11-453

Back to article page